PELTHOS THERAPEUTICS SIGNS MAJOR PHARMACY BENEFIT MANAGER AGREEMENT EXPANDING PATIENT ACCESS TO ZELSUVMI™ (BERDAZIMER) TOPICAL GEL, 10.3%

Reuters · 1d ago

Please log in to view news